CAR T cell Therapy for Gliomas

← Back to the Portfolio

Nature Medicine, May 2018
Volume 24, Issue 5

Diffuse midline gliomas (DMGs) with the histone H3 K27M mutation are fatal pediatric tumors. In this issue, Michelle Monje and colleagues report that CAR T cells targeting the disialoganglioside GD2 are capable of killing DMG cells in preclinical models, offering hope for clinical translation of this immunotherapy. The cover depicts a tiger attacking hyenas, which do not naturally coexist in the same geographic region, to represent an exogenously introduced CAR T cell attacking glioma cells.

Adobe Illustrator and Photoshop

CAR T cell Therapy for Gliomas

Similar Projects

lncRNA Nuclear Enrichment Signals

lncRNA Nuclear Enrichment Signals

EMBO Journal, 15 March 2018 Volume 37, Issue 6 lncRNA Nuclear Enrichment Signals by Chinmay Shukla, Philipp Maas, John Rinn et al: High-throughput identification of RNA nuclear enrichment sequences. RNA […]

Organism-level analysis of vaccination

Organism-level analysis of vaccination

Cover proposal for Cell October 2017 The image in form of a mandala is a representation of diverse tissue and organs that are involved in immune response to vaccination forming […]

Gene profiling reveals gene networks and interactions

Gene profiling reveals gene networks and interactions

Cell, February 23, 2017 Volume 168, Number 5 In this issue, Wang et al. conducted genome-wide CRISPR-Cas9 screens to identify essential genes across a panel of cancer cell lines. Global […]